Microbiology of diabetic foot infections: From Louis Pasteur to 'crime scene investigation'

BMC Medicine

Volumn 13, Issue 1, 2015, Pages

  Spichler, Anne ^a   Hurwitz, Bonnie L ^b   Armstrong, David G ^a   Lipsky, Benjamin A ^c,d  

^a UNIVERSITY OF ARIZONA   (United States)

^b University of Arizona   (United States)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Diabetic foot infection; High throughput sequencing; Metagenomics; Microbiology; Molecular diagnostics

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE; HEMOLYSIN; LEUKOCIDIN; STAPHYLOCOCCUS ENTEROTOXIN; STAPHYLOCOCCUS ENTEROTOXIN A; RNA 16S; VIRULENCE FACTOR;

ARTICLE; BACTERIAL LOAD; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CRIME SCENE INVESTIGATION; DIABETIC FOOT; DIABETIC FOOT INFECTION; DISEASE COURSE; DNA MICROARRAY; HUMAN; INVESTIGATIVE PROCEDURES; METAGENOMICS; METAMORPHOSIS; MICROBIAL DIVERSITY; MICROBIOLOGY; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; PSEUDOMONAS AERUGINOSA; PYROSEQUENCING; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANT ENTEROCOCCUS; WOUND INFECTION; BACTERIAL INFECTIONS; BACTERIUM; GENETICS; ISOLATION AND PURIFICATION; PATHOGENICITY; STAPHYLOCOCCUS INFECTION;

BACTERIA; BACTERIAL INFECTIONS; BACTERIAL LOAD; DIABETIC FOOT; HUMANS; METAGENOMICS; POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

EID: 84924338387     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-014-0232-0     Document Type: Article

References (64)

1. Vallery-Radot R: The Life of Pasteur, vol. II. In Translation from the French by Mrs RL Devonshire. 1902.
2. Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA: Risk factors for foot infections in individuals with diabetes. Diabetes Care 2006, 29:1288-1293.
3. Singh N, Armstrong DG, Lipsky BA: Preventing foot ulcers in patients with diabetes. JAMA 2005, 293:217-228.
4. Prompers L, Schaper N, Apelqvist J, Edmonds M, Jude E, Mauricio D, Uccioli L, Urbancic V, Bakker K, Holstein P, Jirkovska A, Piaggesi A, Ragnarson-Tennvall G, Reike H, Spraul M, Van Acker K, Van Baal J, Van Merode F, Ferreira I, Huijberts M: Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease: The EURODIALE Study. Diabetologia 2008, 51:747-755.
5. Lavery LA, Armstrong DG, Murdoch DP, Peters EJG, Lipsky BA: Validation of the Infectious Diseases Society of America's diabetic foot infection classification system. Clin Infect Dis 2007, 44:562-565.
6. Skrepnek GH, Armstrong DG, Mills JL: Open bypass and endovascular procedures among diabetic foot ulcer cases in the United States from 2001 to 2010. J Vasc Surg 2014. doi:10.1016/j.jvs.2014.04.071
7. Fisher TK, Wolcott R, Wolk DM, Bharara M, Kimbriel HR, Armstrong DG: Diabetic foot infections: a need for innovative assessments. Int J Low Extrem Wounds 2010, 9:31-36.
8. Richard JL, Lavigne JP, Sotto A: Diabetes and foot infection: more than double trouble. Diabetes Metab Res Rev 2012, 28:46-53.
9. Gardner SE, Frantz RA: Wound bioburden and infection-related complications in diabetic foot ulcers. Biol Res Nurs 2008, 10:44-53.
10. Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, Deery HG, Embil JM, Joseph WS, Karchmer AW, Pinzur MS, Senneville E, Infectious Diseases Society of America: Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012, 2012:e132-e173.
11. Brem H, Tomic-Canic M: Cellular and molecular basis of wound healing in diabetes. J Clin Invest 2007, 117:1219-1222.
12. Richard JL, Sotto A, Lavigne JP: New insights in diabetic foot infection. World J Diabetes 2011, 2:24-32.
13. Cutting KF, White R: Defined and refined: criteria for identifying wound infection revisited. Br J Community Nurs 2004, 9:S6-S15.
14. Robson MC, Mannari RJ, Smith PD, Payne WG: Maintenance of wound bacterial balance. Am J Surg 1999, 178:399-402.
15. Cutting KF, White RJ: Criteria for identifying wound infection-revisited. Ostomy Wound Manage 2005, 51:28-34.
16. Gardner SE, Hillis SL, Frantz RA: Clinical signs of infection in diabetic foot ulcers with high microbial load. Biol Res Nurs 2009, 11:119-128.
17. Xu L, McLennan SV, Lo L, Natfaji A, Bolton T, Liu Y, Twigg SM, Yue DK: Bacterial load predicts healing rate in neuropathic diabetic foot ulcers. Diabetes Care 2007, 30:378-380.
18. Gardner SE, Haleem A, Jao YL, Hillis SL, Femino JE, Phisitkul P, Heilmann KP, Lehman SM, Franciscus CL: Cultures of diabetic foot ulcers without clinical signs of infection do not predict outcomes. Diabetes Care 2014, 37:2693-2701.
19. Citron DM, Goldstein EJ, Merriam CV, Lipsky BA, Abramson MA: Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol 2007, 45:2819-2828.
20. Roberts AD, Simon GL: Diabetic foot infections: the role of microbiology and antibiotic treatment. Semin Vasc Surg 2012, 25:75-81.
21. Uçkay I, Gariani K, Pataky Z, Lipsky BA: Diabetic foot infections: state-of-the-art. Diabetes Obes Metab 2013, 16:305-316.
22. Armstrong DG, Lavery LA, Nixon BP, Boulton AJ: It's not what you put on, but what you take off: techniques for debriding and off-loading the diabetic foot wound. Clin Infect Dis 2004, 39:S92-S99.
23. Lavigne JP, Sotto A, Dunyach-Remy C, Lipsky BA: New molecular techniques to study the skin microbiota of diabetic foot ulcers. Adv Wound Care 2014. doi:10.1089/wound.2014.0532.
24. Bansal E, Garg A, Bhatia S, Attri AK, Chander J: Spectrum of microbial flora in diabetic foot ulcers. Indian J Pathol Microbiol 2008, 51:204-208.
25. Dowd SE, Wolcott RD, Sun Y, McKeehan T, Smith E, Rhoads D: Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS One 2008, 3:e3326.
26. Lipsky BA: Diabetic foot infections: microbiology made modern? Array of hope. Diabetes Care 2007, 30:2171-2172.
27. Sotto A, Richard JL, Jourdan N, Combescure C, Bouziges N, Lavigne JP, Nîmes University Hospital Working Group on the Diabetic Foot (GP30): Miniaturized oligonucleotide arrays: a new tool for discriminating colonization from infection due to Staphylococcus aureus in diabetic foot ulcers. Diabetes Care 2007, 30:2051-2056.
28. Sotto A, Lina G, Richard JL, Combescure C, Bourg G, Vidal L, Jourdan N, Etienne J, Lavigne JP: Virulence potential of Staphylococcus aureus strains isolated from diabetic foot ulcers: a new paradigm. Diabetes Care 2008, 31:2318-2324.
29. Sotto A, Richard JL, Messad N, Molinari N, Jourdan N, Schuldiner S, Sultan A, Carrière C, Canivet B, Landraud L, Lina G, Lavigne JP, the French Study Group on the Diabetic Foot: Distinguishing colonization from infection with Staphylococcus aureus in diabetic foot ulcers with miniaturized oligonucleotide arrays: a French multicenter study. Diabetes Care 2012, 35:617-623.
30. Lipsky BA, Richard JL, Lavigne JP: Diabetic foot ulcer microbiome: one small step for molecular microbiology. One giant leap for understanding diabetic foot ulcers? Diabetes 2013, 62:679-681.
31. Lipsky BA, Armstrong DG, Citron DM, Tice AD, Morgenstern DE, Abramson MA: Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Lancet 2005, 366:1695-1703.
32. Price LB, Liu CM, Melendez JH, Frankel YM, Engelthaler D, Aziz M, Bowers J, Rattray R, Ravel J, Kingsley C, Keim PS, Lazarus GS, Zenilman JM: Community analysis of chronic wound bacteria using 16S rRNA gene-based pyrosequencing: impact of diabetes and antibiotics on chronic wound microbiota. PLoS One 2009, 4:e6462.
33. Smith DM, Snow DE, Rees E, Zischkau AM, Hanson JD, Wolcott RD, Sun Y, White J, Kumar S, Dowd SE: Evaluation of the bacterial diversity of pressure ulcers using bTEFAP pyrosequencing. BMC Med Genomics 2010, 3:41.
34. Gardner SE, Hillis SL, Heilmann K, Segre JA, Grice EA: The neuropathic diabetic foot ulcer microbiome is associated with clinical factors. Diabetes 2013, 62:923-930.
35. Senneville E, Melliez H, Beltrand E, Legout L, Valette M, Cazaubiel M, Cordonnier M, Caillaux M, Yazdanpanah Y, Mouton Y: Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. Clin Infect Dis 2005, 42:57-62.
36. Senneville E, Morant H, Descamps D, Dekeyser S, Beltrand E, Singer B, Caillaux M, Boulogne A, Legout L, Lemaire X, Lemaire C, Yazdanpanah Y: Needle puncture and transcutaneous bone biopsy cultures are inconsistent in patients with diabetes and suspected osteomyelitis of the foot. Clin Infect Dis 2009, 48:888-893.
37. Armstrong DG, Lipsky BA: Diabetic foot infections: stepwise medical and surgical management. Int Wound J 2004, 1:123-132.
38. Hugenholtz P, Goebel BM, Pace NR: Impact of culture-independent studies on the emerging phylogenetic view of bacterial diversity. J Bacteriol 1998, 180:4765-4773. A published erratum appears in J Bacteriol 1998, 180:6793.
39. Grice EA, Kong HH, Renaud G, Young AC, NISC Comparative Sequencing Program, Bouffard GG, Blakesley RW, Wolfsberg TG, Turner ML, Segre JA: A diversity profile of the human skin microbiota. Genome Res 2008, 18:1043-1050.
40. Dowd SE, Sun Y, Secor PR, Rhoads DD, Wolcott BM, James GA, Wolcott RD: Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 2008, 8:43.
41. Lipsky BA: New developments in diagnosing and treating diabetic foot infections. Diabetes Metab Res Rev 2008, 24:S66-S71.
42. Handelsman J, Rondon MR, Brady SF, Clardy J, Goodman RM: Molecular biological access to the chemistry of unknown soil microbes: a new frontier for natural products. Chem Biol 1998, 5:R245-R249.
43. Pace NR, Stahl DA, Lane DJ, Olsen GJ: The analysis of natural microbial-populations by ribosomal-RNA sequences. Adv Microb Ecol 1986, 9:1-55.
44. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, et al: A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
45. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, et al: Enterotypes of the human gut microbiome. Nature 2011, 473:174-180.
46. Human Microbiome Project Consortium: Structure, function and diversity of the healthy human microbiome. Nature 2012, 486:207-214.
47. 454 Life Sciences, a Roche Company. [http://www.454.com]
48. llumina |Sequencing and array-based solutions for genetic research. [http://www.illumina.com]
49. Ion Torrent. [http://tools.lifetechnologies.com/content/sfs/brochures/Small_Genome_Brochure.pdf]
50. Willner D, Hugenholtz P: Metagenomics and community profiling: culture-independent techniques in the clinical laboratory. Clin Microbiol Newsl 2013, 35:1-9.
51. Mignard S, Flandrois JP: 16S rRNA sequencing in routine bacterial identification: a 30-month experiment. J Microbiol Methods 2006, 67:574-581.
52. Sibley CD, Peirano G, Church DL: Molecular methods for pathogen and microbial community detection and characterization: current and potential application in diagnostic microbiology. Infect Genet Evol 2012, 12:505-521.
53. Riesenfeld CS, Schloss PD, Handelsman J: Metagenomics: genomic analysis of microbial communities. Annu Rev Genet 2004, 38:525-552.
54. Kunin V, Copeland A, Lapidus A, Mavromatis K, Hugenholtz P: A bioinformatician's guide to metagenomics. Microbiol Mol Biol Rev 2008, 72:557-578. Table of Contents.
55. Tyson GW, Chapman J, Hugenholtz P, Allen EE, Ram RJ, Richardson PM, Solovyev VV, Rubin EM, Rokhsar DS, Banfield JF: Community structure and metabolism through reconstruction of microbial genomes from the environment. Nature 2004, 428:37-43.
56. Wintzingerode F, Göbel U: Determination of microbial diversity in environmental samples: pitfalls of PCR-based rRNA analysis. FEMS Microbiol Rev 1997, 21:213-229.
57. Klein D: Quantification using real-time PCR technology: applications and limitations. Trends Mol Med 2002, 8:257-260.
58. Yang S, Rothman RE: PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet Infect Dis 2004, 4:337-348.
59. Kunin V, Engelbrektson A, Ochman H, Hugenholtz P: Wrinkles in the rare biosphere: pyrosequencing errors can lead to artificial inflation of diversity estimates. Environ Microbiol 2010, 12:118-123.
60. Grice EA, Segre JA: The skin microbiome. Nat Rev Microbiol 2011, 9:244-253.
61. Rhoads DD, Wolcott RD, Sun Y, Dowd SE: Comparison of culture and molecular identification of bacteria in chronic wounds. Int J Mol Sci 2012, 13:2535-2550.
62. Salipante SJ, Sengupta DJ, Rosenthal C, Costa G, Spangler J, Sims EH, Jacobs MA, Miller SI, Hoogestraat DR, Cookson BT, McCoy C, Matsen FA, Shendure J, Lee CC, Harkins TT, Hoffman NG: Rapid 16S rRNA next-generation sequencing of polymicrobial clinical samples for diagnosis of complex bacterial infections. PLoS One 2013, 8:e65226.
63. Caliendo AM, Gilbert DN, Ginocchio CC, Hanson KE, May L, Quinn TC, Tenover FC, Alland D, Blaschke AJ, Bonomo RA, Carroll KC, Ferraro MJ, Hirschhorn LR, Joseph WP, Karchmer T, MacIntyre AT, Reller LB, Jackson AF, Infectious Diseases Society of America (IDSA): Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis 2013, 57:S139-S170.
64. "CSI: Crime Scene Investigation" Pilot (TV Episode 2000). [http://www.imdb.com/title/tt0534724/quotes]